279 related articles for article (PubMed ID: 26721264)
1. Association Between Antipsychotic Treatment and Advanced Diabetes Complications Among Schizophrenia Patients With Type 2 Diabetes Mellitus.
Wu CS; Gau SS
Schizophr Bull; 2016 May; 42(3):703-11. PubMed ID: 26721264
[TBL] [Abstract][Full Text] [Related]
2. Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People With Schizophrenia: A Danish Population-Based Cohort Study.
Rajkumar AP; Horsdal HT; Wimberley T; Cohen D; Mors O; Børglum AD; Gasse C
Am J Psychiatry; 2017 Jul; 174(7):686-694. PubMed ID: 28103712
[TBL] [Abstract][Full Text] [Related]
3. Complications and mortality in patients with schizophrenia and diabetes: population-based cohort study.
Wu CS; Lai MS; Gau SS
Br J Psychiatry; 2015 Nov; 207(5):450-7. PubMed ID: 26294369
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
[TBL] [Abstract][Full Text] [Related]
5. Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders.
Wu CS; Wang SC; Yeh IJ; Liu SK
J Clin Psychiatry; 2016 May; 77(5):e573-9. PubMed ID: 27249081
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of dementia in patients with Schizophrenia: A population-based cohort study in Taiwan.
Lin CE; Chung CH; Chen LF; Chi MJ
Eur Psychiatry; 2018 Sep; 53():7-16. PubMed ID: 29859379
[TBL] [Abstract][Full Text] [Related]
7. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
8. Altered metabolic parameters in association with antipsychotic medication use in diabetes: A population based case-control study.
Wake DJ; Broughton P; Perera SM; MacIntyre DJ; Leese GP
Psychoneuroendocrinology; 2016 Apr; 66():214-20. PubMed ID: 26849203
[TBL] [Abstract][Full Text] [Related]
9. Associations Between Antidepressant Use and Advanced Diabetes Outcomes in Patients with Depression and Diabetes Mellitus.
Wu CS; Hsu LY; Pan YJ; Wang SH
J Clin Endocrinol Metab; 2021 Nov; 106(12):e5136-e5146. PubMed ID: 34259856
[TBL] [Abstract][Full Text] [Related]
10. Incidence and costs of cardiometabolic conditions in patients with schizophrenia treated with antipsychotic medications.
Jerrell JM; McIntyre RS; Tripathi A
Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):161-8. PubMed ID: 20880826
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India.
Pallava A; Chadda RK; Sood M; Lakshmy R
Nord J Psychiatry; 2012 Jun; 66(3):215-21. PubMed ID: 22017264
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment.
Cohen D; Dekker JJ; Peen J; Gispen-de Wied CC
Eur Neuropsychopharmacol; 2006 Apr; 16(3):187-94. PubMed ID: 16263247
[TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data.
Lipscombe LL; Austin PC; Alessi-Severini S; Blackburn DF; Blais L; Bresee L; Filion KB; Kawasumi Y; Kurdyak P; Platt RW; Tamim H; Paterson JM;
Schizophr Res; 2014 Apr; 154(1-3):54-60. PubMed ID: 24581419
[TBL] [Abstract][Full Text] [Related]
14. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.
Tiihonen J; Haukka J; Taylor M; Haddad PM; Patel MX; Korhonen P
Am J Psychiatry; 2011 Jun; 168(6):603-9. PubMed ID: 21362741
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of diabetes and antipsychotic prescription patterns in patients with schizophrenia: a nationwide retrospective cohort study.
Okumura Y; Ito H; Kobayashi M; Mayahara K; Matsumoto Y; Hirakawa J
Schizophr Res; 2010 Jun; 119(1-3):145-52. PubMed ID: 20304611
[TBL] [Abstract][Full Text] [Related]
16. Diabetes prevalence estimates in schizophrenia and risk factor assessment.
Argo T; Carnahan R; Barnett M; Holman TL; Perry PJ
Ann Clin Psychiatry; 2011 May; 23(2):117-24. PubMed ID: 21547272
[TBL] [Abstract][Full Text] [Related]
17. Association of depression and diabetes complications and mortality: a population-based cohort study.
Wu CS; Hsu LY; Wang SH
Epidemiol Psychiatr Sci; 2020 Jan; 29():e96. PubMed ID: 31992379
[TBL] [Abstract][Full Text] [Related]
18. A retrospective cohort study on the risk of stroke in relation to a priori health knowledge level among people with type 2 diabetes mellitus in Taiwan.
Lai YJ; Hu HY; Lee YL; Ku PW; Yen YF; Chu D
BMC Cardiovasc Disord; 2017 May; 17(1):130. PubMed ID: 28532430
[TBL] [Abstract][Full Text] [Related]
19. Associations among antipsychotics, metabolism-related diseases, and cataracts in patients with schizophrenia: A retrospective cohort study.
Fang SC; Huang CY; Liao DL; Hsu CC; Shao YJ
Schizophr Res; 2019 Oct; 212():150-156. PubMed ID: 31395489
[TBL] [Abstract][Full Text] [Related]
20. Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.
Citrome LL; Holt RI; Zachry WM; Clewell JD; Orth PA; Karagianis JL; Hoffmann VP
Ann Pharmacother; 2007 Oct; 41(10):1593-603. PubMed ID: 17785613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
